INBIOGEN Co., Ltd. (KRX:101140)
South Korea · Delayed Price · Currency is KRW 5,320.00
0.00 (0.00%)
At close: Aug 21, 2026
INBIOGEN Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 53,119 | 104,740 | 93,258 | 93,320 | 51,597 | 186,337 | |
Market Cap Growth | -54.80% | 12.31% | -0.07% | 80.86% | -72.31% | -26.46% |
Enterprise Value | 54,829 | 104,457 | 89,287 | 87,747 | 118,105 | 125,455 |
Last Close Price | 5320.00 | 10490.00 | 9340.00 | 9340.00 | 15500.00 | 71200.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 5.78 | 8.23 | - | 1.98 |
PS Ratio | 10.41 | 16.63 | 13.25 | 14.95 | 4.95 | 17.78 |
PB Ratio | 0.38 | 0.66 | 0.58 | 0.65 | 0.37 | 0.82 |
P/TBV Ratio | 0.38 | 0.66 | 0.58 | 0.66 | 0.49 | 1.05 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 10.74 | 16.59 | 12.68 | 14.06 | 11.34 | 11.97 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.03 | 0.01 | 0.01 | 0.00 | 0.01 | 0.06 |
Net Debt / Equity Ratio | 0.01 | 0.00 | -0.03 | -0.04 | -0.05 | -0.04 |
Net Debt / EBITDA Ratio | -0.45 | -0.07 | 0.96 | 1.11 | 1.66 | 1.39 |
Net Debt / FCF Ratio | -0.47 | -0.05 | 41.07 | 5.10 | 0.65 | 1.03 |
Asset Turnover | 0.03 | 0.04 | 0.05 | 0.04 | 0.05 | 0.06 |
Inventory Turnover | - | 94.79 | 12.99 | 4.10 | 5.61 | 6.94 |
Quick Ratio | 1.37 | 2.79 | 4.32 | 4.90 | 3.92 | 1.07 |
Current Ratio | 1.37 | 2.86 | 4.38 | 5.36 | 4.39 | 1.15 |
Return on Equity (ROE) | -13.63% | -0.89% | 10.64% | 8.39% | -63.67% | 61.55% |
Return on Assets (ROA) | -1.57% | -1.68% | -2.47% | -2.66% | -1.78% | -2.74% |
Return on Invested Capital (ROIC) | -2.73% | -2.77% | -4.16% | -4.57% | -3.41% | -6.22% |
Return on Capital Employed (ROCE) | -2.80% | -2.70% | -3.80% | -4.30% | -4.20% | -3.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -39.02% | -1.35% | 17.29% | 12.16% | -227.18% | 50.51% |
FCF Yield | -6.85% | -5.34% | -0.13% | -1.15% | -22.55% | -5.06% |
Buyback Yield / Dilution | - | - | -17.33% | -134.70% | -21.34% | -44.57% |